Pertussis Completed Phase 2 Trials for Meningococcal polysaccharide vaccine group C (DB13890)

Also known as: Whooping cough due to Bordetella pertussis / Whooping Cough / Whooping cough due to bordetella pertussis (B. pertussis)

IndicationStatusPhase
DBCOND0014696 (Pertussis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01171989Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster DosePrevention